CLSDQ
Clearside Biomedical, Inc.
Key Financials
Revenue
$1.7M
↓ 79.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 15-12G | 1/7/2026 | View on SEC |
| 8-K | 12/29/2025 | View on SEC |
| EFFECT | 12/16/2025 | View on SEC |
| EFFECT | 12/16/2025 | View on SEC |
| S-8 POS | 12/15/2025 | View on SEC |
| S-8 POS | 12/15/2025 | View on SEC |
| S-8 POS | 12/15/2025 | View on SEC |
| S-8 POS | 12/15/2025 | View on SEC |
| S-8 POS | 12/15/2025 | View on SEC |
| S-8 POS | 12/15/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CLSDQ |
| Company Name | Clearside Biomedical, Inc. |
| CIK | 1539029 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 678-270-3631 |